Henan Chenglou Pharmaceutical

Henan Chenglou Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and high-end chemical intermediates. The company is particularly recognized for its expertise in nucleoside chemistry, providing key building blocks for antiviral medications, including treatments for COVID-19 and hepatitis. Operating out of Henan province, it serves as a critical supplier in the global pharmaceutical supply chain, offering CDMO services to international partners. Their facilities are designed to meet GMP standards, supporting the production of complex small molecule therapeutics across various therapeutic areas such as anti-infectives and oncology. The company has established a strong presence in the synthesis of nucleoside analogs, which are essential for the development of modern antiviral and anti-tumor drugs.